Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

Thank You!

Your message has been sent.

Oops, message not sent.

Please make sure fields are complete.

News

Virtual Dialogue has 93 Registrations Far Exceeding Expectations


In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

Read Article

Virtual Dialogue has 93 Registrations Far Exceeding Expectations


In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group…

Read Article

Seventy Registrations for Virtual Dialogue: Straight Talk About Chondrosarcoma


Read Article

Results of A Phase 1 Study on Ivosidenib for Patients with Advanced Chondrosarcoma


Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma William D. Tap, MD1,2; Victor M. Villalobos, MD, PhD3; Gregory M. Cote, MD, PhD4; Howard Burris, MD5; Filip Janku, MD,…

Read Article

Clinical Trial on IDH1 Inhibitor Shows Success in Decreasing Chondrosarcoma Cells


Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina…

Read Article

Invitation to Register for Virtual Dialogue: Straight Talk About Chondrosarcoma


Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma…

Read Article

Clinical Research Study by Jonathan Trent on Effectiveness of IDH Inhibitors in Chondrosarcoma


The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase Gabriel Tinoco, MD, Breelyn A. Wilky, MD, Ana Paz-Mejia, MS, Andrew Rosenberg, MD, Jonathan C. Trent, MD, PhD Jonathan Trent, M.D., Ph.D. is a world…

Read Article

Medical Book on Sarcoma’s from Jonathan Trent, M.D.


Sarcomas: Evidence-Based Diagnosis and Management Jonathan C. Trent, Andrew E. Rosenberg, Raphael Pollock, Thomas F. Delaney Springer Publishing Company, Incorporated, 2020 – Medical – 434 pages Jonathan Trent, M.D.,Ph.D. is the leader of the…

Read Article

Contact Information


If you would like to learn more about CS Foundation or if you would like to learn more about the resources we provide to patients, families, caregivers, and physicians, please contact us by phone or send us a message.

**A Registered 501c3 Non-Profit Charity Organization. All donations are tax-deductible.**

Send a Message